The aforementioned results suggest that PNA-modified liposomes exhibit effective MUC1-targeting properties in colorectal cancer cells and could work as efficient drug delivery carriers to MUC1-positive colorectal cancer. The gene discussed is MUC1; the disease is colorectal cancer.